VVM
Versant Venture Management Portfolio holdings
AUM
$82.1M
This Quarter Return
+10.75%
1 Year Return
-26.22%
3 Year Return
+73.87%
5 Year Return
-1.11%
10 Year Return
+1,578.11%
AUM
$114M
AUM Growth
+$114M
(+8.7%)
Cap. Flow
+$4.97M
Cap. Flow
% of AUM
4.37%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
–
Closed
–
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLVS
1
DELISTED
Clovis Oncology, Inc.
CLVS
| $60.5M | 53.2% | 814,833 | – | – |
|
|
FPRX
2
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $25M | 21.95% | 1,092,152 | – | – |
|
|
AKAO
3
DELISTED
Achaogen, Inc.
AKAO
| $12.5M | 11% | 1,281,152 | – | – |
|
|
CBAY
4
DELISTED
Cymabay Therapeutics
CBAY
| $7.26M | 6.38% | 1,048,601 | – | – |
|
5
Inogen
INGN
$216M
| $4.97M | 4.37% | +155,284 | New | +$4.97M |
|
|
KYTH
6
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $3.53M | 3.1% | 70,376 | – | – |
|